Aligos Therapeutics, Inc. Stock Issued During Period, Shares, Reverse Stock Splits
Aligos Therapeutics, Inc. (ALGS) had Stock Issued During Period, Shares, Reverse Stock Splits of 3.30 million shares as of 2024-08-19, per its 10-K filed 2026-03-05.
Financial Statements › Shareholders' Equity
us-gaap:StockIssuedDuringPeriodSharesReverseStockSplits · last filed 2026-03-05
- 2024-08-19: Stock Issued During Period, Shares, Reverse Stock Splits 3.30M shares.
| Period end | Stock Issued During Period, Shares, Reverse Stock Splits |
|---|---|
| 2024-08-19 | 3.30M shares 10-K · filed 2026-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |